MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm14248922

Медицинская библиотека · Journal of clinical medicine · 2025

Clinical and Genetic Factors Associated with Non-Response to Erenumab.

Mallucci Giulia, Terrazzino Salvatore, Giacon Martina, Cordella Alberto, Cargnin Sarah, Schankin Christoph, Gobbi Claudio, Zecca Chiara

СтатьяПеревод в очереди

Аннотация

Background

Monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway, such as erenumab (ERE), are effective migraine-preventive therapies for many patients. Identifying clinical and genetic factors associated with treatment failure is crucial for optimizing patient management.

Methods

This multicenter, prospective observational study included patients with episodic or chronic migraine treated with ERE for 12 months. Demographics, migraine history, comorbidities, treatment outcomes, and genetic variants in CGRP receptor-related genes (CALCRL and RAMP1) were evaluated for associations with non-response to ERE, defined as a <50% reduction in monthly migraine days.

Results

Of the 140 patients starting ERE, 11 were lost to follow up, 12 stopped ERE due to side effects; 18 patients were non-responders and were compared to 99 responders. Arterial hypertension [adjusted OR (aOR): 7.77, p = 0.007], smoking (aOR: 4.98, p = 0.014), and insomnia requiring medication (aOR: 4.51, p = 0.027) were associated with non-responder status. Genetic analysis revealed a nominal association between the RAMP1 rs6431564 polymorphism and non-responder status (nominal p = 0.025), which did not survive Bonferroni correction. The G allele was linked to a reduced risk (aOR per G allele: 0.28, p = 0.025) and caused the increased expression of RAMP1 in an allele-dose manner.

Conclusions

Hypertension, smoking, insomnia requiring medication, and, nominally, the RAMP1 rs6431564 polymorphism were associated with non-responder status to ERE in migraine patients. Further validation of the present results in larger cohorts is needed.

Для цитирования: Mallucci Giulia, Terrazzino Salvatore, Giacon Martina, Cordella Alberto, Cargnin Sarah, Schankin Christoph, Gobbi Claudio, Zecca Chiara. Clinical and Genetic Factors Associated with Non-Response to Erenumab.. Journal of clinical medicine. 2025. DOI: 10.3390/jcm14248922.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.